Cargando…
Network-based drug repurposing for the treatment of COVID-19 patients in different clinical stages
In the severe acute respiratory coronavirus disease 2019 (COVID-19) pandemic, there is an urgent need to develop effective treatments. Through a network-based drug repurposing approach, several effective drug candidates are identified for treating COVID-19 patients in different clinical stages. The...
Autores principales: | Wang, Xin, Wang, Han, Yin, Guosheng, Zhang, Yan Dora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951095/ https://www.ncbi.nlm.nih.gov/pubmed/36855680 http://dx.doi.org/10.1016/j.heliyon.2023.e14059 |
Ejemplares similares
-
Network analytics for drug repurposing in COVID-19
por: Siminea, Nicoleta, et al.
Publicado: (2021) -
Drug repurposing for the treatment of COVID-19
por: Kato, Yuri, et al.
Publicado: (2022) -
Repurposing drugs for treatment of COVID-19
por: Venkatesan, Priya
Publicado: (2021) -
Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics
por: Liu, Dan-Yang, et al.
Publicado: (2021) -
Network bioinformatics analysis provides insight into drug repurposing for COVID-19
por: Li, Xu, et al.
Publicado: (2021)